Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Lancet Glob Health. 2021 Aug 19;9(10):e1423–e1430. doi: 10.1016/S2214-109X(21)00288-6

Table 3:

Baseline demographics and clinical characteristics associated with definite and possible acute rheumatic fever

Definite acute rheumatic fever (n=90) Possible acute rheumatic fever (n=82)

Sex
Male 42 (47%) 39 (48%)
Female 48 (53%) 43 (52%)
Age
Median (IQR) 9(7–12) 10 (8–12)
Evidence of recent streptococcal infection
Positive group A streptococcus throat culture 3 (3%) 3 (4%)
Antistreptolysin O titres (>80% of normal range for age) 60 (67%) 23 (28%)
Antideoxyribonuclease B titres (>80% of normal range for age) 68 (76%) 45 (55%)
Antistreptolysin O titres (>80% of normal range for age) and antideoxyribonuclease B titres (>80% of normal range for age) 46 (51%) 11 (13%)
Joint manifestations
Any joint manifestation 77 (86%) 78 (95%)
 Polyarthritis 26 (29%) 11 (13%)
 Polyarthralgia 45 (50%) 54 (66%)
 Monoarthritis 4 (4%) 1 (1%)
 Monoarthralgia 2 (2%) 12 (15%)
Carditis
Any type of carditis 44 (49%) 1 (1%)
 Mild 7 (8%) 1 (1%)
 Moderate or severe 37 (41%) 0
Normal echocardiogram with prolonged PR interval 6 (7%) 3 (4%)
Chorea 7 (8%) 0
Subcutaneous nodules 0 1 (1%)
Erythema marginatum 0 0
Fever
Any type of fever 84 (93%) 65 (79%)
 Subjective 74 (82%) 50 (61%)
 Objective 10 (11%) 15 (18%)
Elevated markers of inflammation
C-reactive protein (≥5 mg/dL) 58 (64%) 11 (13%)
Erythrocyte sedimentation rate (≥30 mm/h) 46 (51%) 8 (10%)

Data are n (%) unless otherwise indicated.